New Yaz/Yasmin Blood Clot Warnings

Note: Lopez McHugh is no longer accepting cases involving Yaz, Yasmin, Beyaz and gallbladder injury.

On April 10, 2012, the FDA issued yet another warning about Yaz/Yasmin/Beyaz. In this latest move, the drug agency announced that new warnings are required for Yaz, Yasmin, Ocella, and Beyaz. The new warnings report for the first time that studies have shown that these drugs have up to a 3 times higher risk of blood clots than other birth control pills.

There have been many prior warnings indicating a possible increased risk for these drugs, but it was not until April 10, 2012 that the manufacturer provided a clear indication about the research on the Yaz blood clot risk.

On May 31, 2011, the FDA issued its fourth warning regarding Yaz and other drospirenone-containing birth control pills. In this warning, the FDA advised that two recently published studies found an increased risk of blood clots associated with the use of birth control pills containing drospirenone, compared to the risk associated with the use of birth control pills containing levonorgestrel. These new studies were recently published in the prestigious British Medical Journal, and can be found here and here.

The first study found that women using Yaz and other drospirenone-containing birth control pills are two to four times more likely to suffer from a blood clot than women on more established birth control pills.

The second study, although smaller, found that Yaz and drospirenone-containing birth control pills increased the risk of clots by up to 4.7 times the risk for women on more established birth control pills.

Of even more concern is that the women in these studies did not have known risk factors for blood clots. Yaz, Yasmin, and Ocella may be even more dangerous for women with underlying risk factors for blood clots. The European drug regulation authority has already concluded that the warnings for these birth control pills need to be strengthened, based on this new risk information.

The most recent FDA warning can be found here, while the European report can be found here.

Women who have suffered injury as a result of taking Yaz, Yasmin, or Ocella should understand the legal remedies available to them. If you or someone you love developed a blood clot while taking Yaz, Yasmin, or Ocella, you may be eligible to recover damages. Please contact Lopez McHugh for a FREE consultation with a qualified and trusted attorney who can answer your questions and ensure your legal rights are protected. Call today because if you wait too long, you may be barred from recovering for your injuries by your state’s time limits.

Note: The following birth control pills contain drospirenone and all have a higher risk of injury: Beyaz, Gianvi, Loryna, Ocella, Safyral, Syeda, Yasmin, Yaz, and Zarah.

For more information read about: